Bart Steiner

1.3k total citations · 1 hit paper
17 papers, 1.0k citations indexed

About

Bart Steiner is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Bart Steiner has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Bart Steiner's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer-related Molecular Pathways (4 papers). Bart Steiner is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer-related Molecular Pathways (4 papers). Bart Steiner collaborates with scholars based in United States, Spain and Switzerland. Bart Steiner's co-authors include Kamal D. Puri, Brian J. Lannutti, Adam Kashishian, John C. Byrd, Amy J. Johnson, Sarah Meadows, Neill A. Giese, Brian Druker, Jeffrey Tyner and Sarah E.M. Herman and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Bart Steiner

17 papers receiving 997 citations

Hit Papers

CAL-101, a p110δ selective phosphatidylinositol-3-kinase ... 2010 2026 2015 2020 2010 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
    2010 588 citations Brian J. Lannutti, Sarah Meadows et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart Steiner United States 10 518 480 322 311 203 17 1.0k
Ningshu Liu Germany 11 561 1.1× 225 0.5× 224 0.7× 340 1.1× 275 1.4× 30 1.1k
Madlene Oelsner Germany 10 373 0.7× 214 0.4× 135 0.4× 189 0.6× 190 0.9× 11 667
Anagh A. Sahasrabuddhe United States 16 521 1.0× 140 0.3× 261 0.8× 224 0.7× 217 1.1× 23 926
Yukiya Yamamoto Japan 15 834 1.6× 499 1.0× 119 0.4× 211 0.7× 257 1.3× 36 1.8k
Markus Duechler Poland 17 640 1.2× 156 0.3× 88 0.3× 187 0.6× 178 0.9× 29 981
Maria Hottelet United States 8 747 1.4× 118 0.2× 262 0.8× 477 1.5× 303 1.5× 8 1.3k
H Hirai Japan 16 596 1.2× 164 0.3× 65 0.2× 227 0.7× 332 1.6× 36 1.1k
Shelly Gunn United States 12 445 0.9× 148 0.3× 119 0.4× 94 0.3× 298 1.5× 28 814
Jeffrey R. Shearstone United States 15 644 1.2× 139 0.3× 138 0.4× 133 0.4× 85 0.4× 27 1.0k

Countries citing papers authored by Bart Steiner

Since Specialization
Citations

This map shows the geographic impact of Bart Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Steiner more than expected).

Fields of papers citing papers by Bart Steiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Steiner. The network helps show where Bart Steiner may publish in the future.

Co-authorship network of co-authors of Bart Steiner

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Steiner. A scholar is included among the top collaborators of Bart Steiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Steiner. Bart Steiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Matson, Clinton K., Thomas Kenney, Bart Steiner, et al.. (2022). Abstract 3696: GS-9716: A potent, selective and orally bioavailable small molecule inhibitor of MCL1 for the treatment of cancer. Cancer Research. 82(12_Supplement). 3696–3696. 3 indexed citations
2.
Liclican, Albert, Weimei Xing, Gregg Czerwieniec, et al.. (2020). Biochemical characterization of tirabrutinib and other irreversible inhibitors of Bruton's tyrosine kinase reveals differences in on - and off - target inhibition. Biochimica et Biophysica Acta (BBA) - General Subjects. 1864(4). 129531–129531. 74 indexed citations
3.
Horak, Friedrich, Kamal D. Puri, Bart Steiner, et al.. (2016). Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitis. Journal of Allergy and Clinical Immunology. 137(6). 1733–1741. 27 indexed citations
4.
Trevejo-Nuñez, Giraldina, Larry Kane, Bart Steiner, et al.. (2016). Dose-Dependent Suppression of Cytokine production from T cells by a Novel Phosphoinositide 3-Kinase Delta Inhibitor. Scientific Reports. 6(1). 30384–30384. 16 indexed citations
5.
Suárez‐Fueyo, Abel, José M. Rojas, Ariel Cariaga-Martínez, et al.. (2014). Inhibition of PI3Kδ Reduces Kidney Infiltration by Macrophages and Ameliorates Systemic Lupus in the Mouse. The Journal of Immunology. 193(2). 544–554. 38 indexed citations
6.
Tanabe, Natsuko, Adam Kashishian, Bart Steiner, et al.. (2013). Effects of Isoform-selective Phosphatidylinositol 3-Kinase Inhibitors on Osteoclasts. Journal of Biological Chemistry. 288(49). 35346–35357. 36 indexed citations
7.
Kashishian, Adam, Sarah Meadows, Bart Steiner, & Brian J. Lannutti. (2011). Abstract 3555: Anti-tumor activity of CAL-101, a potent selective inhibitor of the p110Δ isoform of PI3K, in models of human glioblastoma. Cancer Research. 71(8_Supplement). 3555–3555. 1 indexed citations
8.
Lannutti, Brian J., Sarah Meadows, Sarah E.M. Herman, et al.. (2010). CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood. 117(2). 591–594. 588 indexed citations breakdown →
9.
Puri, Kamal D., et al.. (2009). IC87114, a Selective Inhibitor of PI3Kδ Suppresses Joint Inflammation and Bone Erosion in Collagen-Induced Arthritis in Rat (50.14). The Journal of Immunology. 182(Supplement_1). 50.14–50.14. 1 indexed citations
10.
11.
Lannutti, Brian J., Adam Kashishian, Sarah Meadows, et al.. (2009). Abstract B136: CAL-120, a novel dual p110β/p110δ phosphatidylinositol-3-kinase (PI3K) inhibitor, attenuates PI3K signaling and demonstrates potent in vivo antitumor activity against solid tumors. Molecular Cancer Therapeutics. 8(12_Supplement). B136–B136. 2 indexed citations
12.
13.
Tjoelker, Larry W., Steve Frey, Christie L. Hunter, et al.. (2000). Structural and Functional Definition of the Human Chitinase Chitin-binding Domain. Journal of Biological Chemistry. 275(1). 514–520. 115 indexed citations
14.
15.
Steiner, Bart, et al.. (1990). Unusual Features of Integrated cDNAs Generated by Infection with Genome-Free Retroviruses. Molecular and Cellular Biology. 10(5). 1891–1900. 17 indexed citations
16.
Steiner, Bart, et al.. (1990). Unusual features of integrated cDNAs generated by infection with genome-free retroviruses.. Molecular and Cellular Biology. 10(5). 1891–1900. 22 indexed citations
17.
Hrushesky, William J.M., et al.. (1984). 24-Hour mean pulse. The American Journal of Medicine. 77(3). 399–406. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ningshu Liu Breakdown of academic impact, for papers by Madlene Oelsner Breakdown of academic impact, for papers by Anagh A. Sahasrabuddhe Breakdown of academic impact, for papers by Yukiya Yamamoto Breakdown of academic impact, for papers by Markus Duechler Breakdown of academic impact, for papers by Maria Hottelet Breakdown of academic impact, for papers by H Hirai Breakdown of academic impact, for papers by Shelly Gunn Breakdown of academic impact, for papers by Jeffrey R. Shearstone
Rankless by CCL
2026